| __timestamp | Alnylam Pharmaceuticals, Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 23006000000 |
| Thursday, January 1, 2015 | 41097000 | 23923000000 |
| Friday, January 1, 2016 | 47159000 | 27889000000 |
| Sunday, January 1, 2017 | 89912000 | 30186000000 |
| Monday, January 1, 2018 | 74908000 | 30821000000 |
| Tuesday, January 1, 2019 | 219750000 | 33754000000 |
| Wednesday, January 1, 2020 | 492853000 | 34099000000 |
| Friday, January 1, 2021 | 844287000 | 34114000000 |
| Saturday, January 1, 2022 | 1037418000 | 29324000000 |
| Sunday, January 1, 2023 | 1828292000 | 30328000000 |
| Monday, January 1, 2024 | 2248243000 |
Data in motion
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. From 2014 to 2023, GSK plc has consistently outperformed Alnylam Pharmaceuticals, Inc. in annual revenue. GSK's revenue peaked in 2020 at approximately $34 billion, maintaining a steady lead over the decade. In contrast, Alnylam's revenue, while growing impressively by over 3,500% from 2014 to 2023, reached its highest point in 2023 at nearly $1.8 billion.
Despite Alnylam's rapid growth, GSK's revenue remains about 17 times larger in 2023. This stark difference highlights GSK's established market presence and diversified portfolio. However, Alnylam's innovative approach and significant growth trajectory suggest a promising future. As the pharmaceutical industry evolves, these two companies exemplify the dynamic balance between established giants and emerging innovators.
Revenue Showdown: Johnson & Johnson vs GSK plc
Who Generates More Revenue? GSK plc or Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: GSK plc vs Alnylam Pharmaceuticals, Inc.
Breaking Down Revenue Trends: GSK plc vs Bausch Health Companies Inc.
GSK plc or Merus N.V.: Who Leads in Yearly Revenue?
GSK plc vs Arrowhead Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.: Annual Revenue Growth Compared
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?